<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03579550</url>
  </required_header>
  <id_info>
    <org_study_id>KA17/151</org_study_id>
    <nct_id>NCT03579550</nct_id>
  </id_info>
  <brief_title>Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus</brief_title>
  <acronym>COH/IUI</acronym>
  <official_title>The Comparison of Reproductive Outcomes of Hsyteroscopic Metroplasty Versus Spontaneous Coitus Plus COH/IUI Cycles in Unexplained Infertile Women With Dysmorphic Uterus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bulent Haydardedeoglu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The correlation between dysmorphic uterus and infertility still remains enigmatic. We aim to
      evaluate the reproductive outcomes of metroplasty via office hysteroscopy in unexplained
      infertile women with dysmorphic uterus with comparing a group of unexplained infertile women
      performing 6 months spontaneous cycles plus 3 cycles controlled ovarian hyperstimulation and
      intrauterine insemination by randomized trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A dysmorphic uterus is a second-class (Class U1) uterine anomaly in the The European Society
      of Human Reproduction and Embryology (ESHRE) and the European Society for Gynaecological
      Endoscopy (ESGE) (ESHRE/ESGE) consensus on the classification of congenital genital tract
      anomalies, which was formerly known as &quot;T-shaped uterus&quot; in the American Fertility Society
      (AFS) Classification of Anomalies of the MÃ¼llerian Duct that leads to poor reproductive and
      obstetric outcomes.

      The reproductive performance of dysmorphic uterus is not well-known issue. We designed a
      randomized trial in unexplained infertile couples women with dysmorphic uterus. After
      allocation of properly selected women, hysteroscopy group will be undertaken metroplasty
      procedure and 9 months follow-up period with natural conception. Second group will be
      undertaken to six months spontaneous coitus and three cycles clomiphene citrate and
      intrauterine insemination cycles. After nine months of follow-up of both groups, the
      pregnancy and reproductive outcomes will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 8, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective randomised trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate (CPR)</measure>
    <time_frame>9 months</time_frame>
    <description>Intrauterine gestational sac with viable fetal heart rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>abortion</measure>
    <time_frame>10 weeks</time_frame>
    <description>the loss of pregnancy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ectopic pregnancy rate</measure>
    <time_frame>10 weeks</time_frame>
    <description>gestation with out of uterine cavity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Hysteroscopy</condition>
  <condition>Pregnancy Rate</condition>
  <condition>Abortion</condition>
  <condition>Ectopic Pregnancy</condition>
  <condition>Intrauterine Insemination</condition>
  <arm_group>
    <arm_group_label>Intervention arm: Hysterocopy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Office hyteroscopic metroplasty will be performed. After oparetion 9 months spontaneous conception Intervention arm for hysteroscopy group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spontaneous cycles plus COH/IUI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Six months spontaneous coitus cycles plus 3 cycles of Clomiphene citrate and intrauterine insemination (COH/IUI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>office hysteroscopic metroplasty intervention arm</intervention_name>
    <description>One group will be performed hysteroscopic metroplasty Second group will be undertaken to six months spontaneous coitus and three cycles of COH/IUI</description>
    <arm_group_label>Intervention arm: Hysterocopy group</arm_group_label>
    <other_name>spontaneous coitus plus COH/IUI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Unexplained infertile couples with;

          1. Dysmorpic uterus in hysterosalpingography

          2. Normal spermiogram

        2. Bilateral patent tubes in hysterosalpingography 3. Normal ovarian reserve (AMH &gt;1.5
        ng/dl and/or total bilateral antral follicle count &gt;8)

        Exclusion Criteria:

          1. Women with history of pelvic surgery including endometriosis and/or tubal surgery

          2. women with endometrioma which was visualised/suspected on transvaginal ultrasonography

          3. Women with anovulation

          4. Women with diminished ovarian reserve (AMH &lt; 1.5 ng/dl and/or total bilateral antral
             follicle count &lt;8)

          5. Couples with abnormal spermiogram parameters (oligospermia, oligoasthenospermia,
             oligoasthenoteratozoospermia, azospermia)

          6. Women with alive children

          7. Obese women (BMI&gt;30 kg/m2)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women with dysmorphic uterus</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bulent Haydardedeoglu, Assoc.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baskent University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bulent Haydardedeoglu</name>
      <address>
        <city>Adana</city>
        <zip>01120</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 26, 2018</study_first_submitted>
  <study_first_submitted_qc>June 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2018</study_first_posted>
  <last_update_submitted>March 11, 2019</last_update_submitted>
  <last_update_submitted_qc>March 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>Bulent Haydardedeoglu</investigator_full_name>
    <investigator_title>Associate Prof. M.D.</investigator_title>
  </responsible_party>
  <keyword>dysmorphic uterus, metroplasty, hysteroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy, Ectopic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

